{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:16:52Z","timestamp":1789661812805,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,11]]},"DOI":"10.7759\/cureus.22112","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T10:49:23Z","timestamp":1644576563000},"source":"Crossref","is-referenced-by-count":8,"title":["Sepsis Management, Controversies, and Advancement in Nanotechnology: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Rabia","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijso.2020.11.016","article-title":"Perioperative management of adult surgical patients with septic shock in resource limiting setting, systematic review","volume":"29","author":"Alemu ET","year":"2021","unstructured":"Alemu ET, Agegnehu AF, Temesgen MM. Perioperative management of adult surgical patients with septic shock in resource limiting setting, systematic review. Int J Surg Open. 2021, 29:66-75. 10.1016\/j.ijso.2020.11.016","journal-title":"Int J Surg Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00702-6","article-title":"Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology","volume":"28","author":"Pant A","year":"2021","unstructured":"Pant A, Mackraj I, Govender T. Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology. J Biomed Sci. 2021, 28:6. 10.1186\/s12929-020-00702-6","journal-title":"J Biomed Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2018.10.034","article-title":"Recent advances in biosensors for diagnosis and detection of sepsis: a comprehensive review","volume":"124-125","author":"Kumar S","year":"2019","unstructured":"Kumar S, Tripathy S, Jyoti A, Singh SG. Recent advances in biosensors for diagnosis and detection of sepsis: a comprehensive review. Biosens Bioelectron. 2019, 124-125:205-15. 10.1016\/j.bios.2018.10.034","journal-title":"Biosens Bioelectron"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5339\/qmj.2019.qccc.8","article-title":"Biomarkers for sepsis - past, present and future","volume":"2019","author":"Singer M","year":"2019","unstructured":"Singer M. Biomarkers for sepsis - past, present and future. Qatar Med J. 2019, 2019:8. 10.5339\/qmj.2019.qccc.8","journal-title":"Qatar Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: a review","volume":"14","author":"Pierrakos C","year":"2010","unstructured":"Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010, 14:R15. 10.1186\/cc8872","journal-title":"Crit Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss RS","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016, 2:16045. 10.1038\/nrdp.2016.45","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004363","article-title":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","volume":"48","author":"Alhazzani W","year":"2020","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, et al.. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020, 48:e440-69. 10.1097\/CCM.0000000000004363","journal-title":"Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000142910.01076.a5","article-title":"Adjunctive therapies in sepsis: an evidence-based review","volume":"32","author":"Cariou A","year":"2004","unstructured":"Cariou A, Vinsonneau C, Dhainaut JF. Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med. 2004, 32:S562-70. 10.1097\/01.ccm.0000142910.01076.a5","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5786182","article-title":"Sepsis: diagnostic and therapeutic challenges","volume":"2016","author":"Moln\u00e1r Z","year":"2016","unstructured":"Moln\u00e1r Z, Giamarellos-Bourboulis EJ, Kumar A, Nierhaus A. Sepsis: diagnostic and therapeutic challenges. Biomed Res Int. 2016, 2016:5786182. 10.1155\/2016\/5786182","journal-title":"Biomed Res Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13534-021-00200-0","article-title":"Sepsis diagnosis and treatment using nanomaterials","author":"Lim J","year":"2021","unstructured":"Lim J, Lee YY, Choy YB, Park W, Park CG. Sepsis diagnosis and treatment using nanomaterials. Biomed Eng Lett. 2021, 1-14. 10.1007\/s13534-021-00200-0","journal-title":"Biomed Eng Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-018-0165-6","article-title":"Raising concerns about the Sepsis-3 definitions","volume":"13","author":"Sartelli M","year":"2018","unstructured":"Sartelli M, Kluger Y, Ansaloni L, et al.. Raising concerns about the Sepsis-3 definitions. World J Emerg Surg. 2018, 13:6. 10.1186\/s13017-018-0165-6","journal-title":"World J Emerg Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2015-1","article-title":"Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis","volume":"10","author":"Cao C","year":"2019","unstructured":"Cao C, Yu M, Chai Y. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis. 2019, 10:782. 10.1038\/s41419-019-2015-1","journal-title":"Cell Death Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.12.4.580","article-title":"Norepinephrine with dopamine infusion on the end-tidal carbon dioxide (ETco2) pressure in patients with septic shock","volume":"12","author":"Sazgar M","year":"2021","unstructured":"Sazgar M, Golikhatir I, Pashaee SM, Tirandaz F, Firouzian A, Miniahidashti H. Norepinephrine with dopamine infusion on the end-tidal carbon dioxide (ETco2) pressure in patients with septic shock. Caspian J Intern Med. 2021, 12:580-5. 10.22088\/cjim.12.4.580","journal-title":"Caspian J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.025","article-title":"Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial","volume":"158","author":"Douglas IS","year":"2020","unstructured":"Douglas IS, Alapat PM, Corl KA, et al.. Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial. Chest. 2020, 158:1431-45. 10.1016\/j.chest.2020.04.025","journal-title":"Chest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001140","article-title":"Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis","volume":"43","author":"Zhang D","year":"2015","unstructured":"Zhang D, Micek ST, Kollef MH. Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med. 2015, 43:2133-40. 10.1097\/CCM.0000000000001140","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95386-9","article-title":"Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis","volume":"11","author":"Fong KM","year":"2021","unstructured":"Fong KM, Au SY, Ng GW. Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis. Sci Rep. 2021, 11:15777. 10.1038\/s41598-021-95386-9","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/tog.12623","article-title":"Maternal sepsis update: current management and controversies","volume":"22","author":"Greer O","year":"2019","unstructured":"Greer O, Shah NM, Johnson MR. Maternal sepsis update: current management and controversies. Obstet Gynaecol. 2019, 22:45-55. 10.1111\/tog.12623","journal-title":"Obstet Gynaecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004476","article-title":"Evaluation of vasopressor exposure and mortality in patients with septic shock","volume":"48","author":"Roberts RJ","year":"2020","unstructured":"Roberts RJ, Miano TA, Hammond DA, et al.. Evaluation of vasopressor exposure and mortality in patients with septic shock. Crit Care Med. 2020, 48:1445-53. 10.1097\/CCM.0000000000004476","journal-title":"Crit Care Med"},{"key":"ref21","article-title":"Updates and controversies in the early management of sepsis and septic shock","volume":"20","author":"Guirgis F","year":"2018","unstructured":"Guirgis F, Black LP, DeVos EL. Updates and controversies in the early management of sepsis and septic shock. Emerg Med Pract. 2018, 20:1-28.","journal-title":"Emerg Med Pract"},{"key":"ref22","article-title":"Updates and controversies in the early management of sepsis and septic shock","volume":"23","author":"Norse AB","year":"2021","unstructured":"Norse AB, Guirgis F, Black LP, DeVos EL. Updates and controversies in the early management of sepsis and septic shock. Emerg Med Pract. 2021, 23:1-24.","journal-title":"Emerg Med Pract"},{"key":"ref23","article-title":"Treatment of patients with severe sepsis and septic shock: current evidence-based practices","volume":"102","author":"Lee J","year":"2019","unstructured":"Lee J, Levy MM. Treatment of patients with severe sepsis and septic shock: current evidence-based practices. R I Med J. 2019, 102:18-21.","journal-title":"R I Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero J","year":"2003","unstructured":"Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003, 31:2742-51. 10.1097\/01.CCM.0000098031.24329.10","journal-title":"Crit Care Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003310","article-title":"The changing paradigm of sepsis: early diagnosis, early antibiotics, early pressors, and early adjuvant treatment","volume":"46","author":"Marik PE","year":"2018","unstructured":"Marik PE, Farkas JD. The changing paradigm of sepsis: early diagnosis, early antibiotics, early pressors, and early adjuvant treatment. Crit Care Med. 2018, 46:1690-2. 10.1097\/CCM.0000000000003310","journal-title":"Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2808203","article-title":"The role of adjunctive therapies in septic shock by gram negative MDR\/XDR infections","volume":"2017","author":"Busani S","year":"2017","unstructured":"Busani S, Roat E, Serafini G, Mantovani E, Biagioni E, Girardis M. The role of adjunctive therapies in septic shock by gram negative MDR\/XDR infections. Can J Infect Dis Med Microbiol. 2017, 2017:2808203. 10.1155\/2017\/2808203","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01318","article-title":"Glucocorticoids in sepsis: to be or not to be","volume":"11","author":"Vandewalle J","year":"2020","unstructured":"Vandewalle J, Libert C. Glucocorticoids in sepsis: to be or not to be. Front Immunol. 2020, 11:1318. 10.3389\/fimmu.2020.01318","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.02.004","article-title":"The initial resuscitation of septic shock","volume":"57","author":"Cinel I","year":"2020","unstructured":"Cinel I, Kasapoglu US, Gul F, Dellinger RP. The initial resuscitation of septic shock. J Crit Care. 2020, 57:108-17. 10.1016\/j.jcrc.2020.02.004","journal-title":"J Crit Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000954","article-title":"A narrative review on antimicrobial therapy in septic shock: updates and controversies","volume":"34","author":"Ling L","year":"2021","unstructured":"Ling L, Joynt GM, Lipman J. A narrative review on antimicrobial therapy in septic shock: updates and controversies. Curr Opin Anaesthesiol. 2021, 34:92-8. 10.1097\/ACO.0000000000000954","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102046","article-title":"Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: new insight for treating COVID-19","volume":"45","author":"Chen L","year":"2021","unstructured":"Chen L, Huang Q, Zhao T, et al.. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: new insight for treating COVID-19. Redox Biol. 2021, 45:102046. 10.1016\/j.redox.2021.102046","journal-title":"Redox Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray PD","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012, 24:981-90. 10.1016\/j.cellsig.2012.01.008","journal-title":"Cell Signal"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101799","article-title":"Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications","volume":"37","author":"Kang Q","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020, 37:101799. 10.1016\/j.redox.2020.101799","journal-title":"Redox Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7370","article-title":"Redox potential and ROS-mediated nanomedicines for improving cancer therapy","volume":"30","author":"Glass SB","year":"2019","unstructured":"Glass SB, Gonzalez-Fajardo L, Beringhs AO, Lu X. Redox potential and ROS-mediated nanomedicines for improving cancer therapy. Antioxid Redox Signal. 2019, 30:747-61. 10.1089\/ars.2017.7370","journal-title":"Antioxid Redox Signal"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll T","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017, 17:407-20. 10.1038\/nri.2017.36","journal-title":"Nat Rev Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation","volume":"15","author":"Zindel J","year":"2020","unstructured":"Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol. 2020, 15:493-518. 10.1146\/annurev-pathmechdis-012419-032847","journal-title":"Annu Rev Pathol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman BG","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017, 39:517-28. 10.1007\/s00281-017-0639-8","journal-title":"Semin Immunopathol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201705328","article-title":"Advances in biomaterials for drug delivery","volume":"30","author":"Fenton OS","year":"2018","unstructured":"Fenton OS, Olafson KN, Pillai PS, Mitchell MJ, Langer R. Advances in biomaterials for drug delivery. Adv Mater. 2018, 30:e1705328. 10.1002\/adma.201705328","journal-title":"Adv Mater"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo AC","year":"2019","unstructured":"Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019, 4:e10143. 10.1002\/btm2.10143","journal-title":"Bioeng Transl Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2021.04.021","article-title":"MoS2-based nanocomposites for cancer diagnosis and therapy","volume":"6","author":"Wang J","year":"2021","unstructured":"Wang J, Sui L, Huang J, et al.. MoS2-based nanocomposites for cancer diagnosis and therapy. Bioact Mater. 2021, 6:4209-42. 10.1016\/j.bioactmat.2021.04.021","journal-title":"Bioact Mater"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-019-0600-1","article-title":"Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis","volume":"15","author":"Hou X","year":"2020","unstructured":"Hou X, Zhang X, Zhao W, et al.. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat Nanotechnol. 2020, 15:41-6. 10.1038\/s41565-019-0600-1","journal-title":"Nat Nanotechnol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02957","article-title":"Citrullinated histone H3 as a therapeutic target for endotoxic shock in mice","volume":"10","author":"Deng Q","year":"2019","unstructured":"Deng Q, Pan B, Alam HB, et al.. Citrullinated histone H3 as a therapeutic target for endotoxic shock in mice. Front Immunol. 2019, 10:2957. 10.3389\/fimmu.2019.02957","journal-title":"Front Immunol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7150\/thno.39662","article-title":"PEGylated bilirubin-coated iron oxide nanoparticles as a biosensor for magnetic relaxation switching-based ROS detection in whole blood","volume":"10","author":"Lee DY","year":"2020","unstructured":"Lee DY, Kang S, Lee Y, et al.. PEGylated bilirubin-coated iron oxide nanoparticles as a biosensor for magnetic relaxation switching-based ROS detection in whole blood. Theranostics. 2020, 10:1997-2007. 10.7150\/thno.39662","journal-title":"Theranostics"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2011.1195","article-title":"An investigation on the approach to target lipopolysaccharide through polymeric capped nano-structured formulation for the management of sepsis","volume":"7","author":"Mishra PR","year":"2011","unstructured":"Mishra PR. An investigation on the approach to target lipopolysaccharide through polymeric capped nano-structured formulation for the management of sepsis. J Biomed Nanotechnol. 2011, 7:47-9. 10.1166\/jbn.2011.1195","journal-title":"J Biomed Nanotechnol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c03697","article-title":"Toward nanotechnology-enabled approaches against the COVID-19 pandemic","volume":"14","author":"Weiss C","year":"2020","unstructured":"Weiss C, Carriere M, Fusco L, et al.. Toward nanotechnology-enabled approaches against the COVID-19 pandemic. ACS Nano. 2020, 14:6383-406. 10.1021\/acsnano.0c03697","journal-title":"ACS Nano"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2014.06.003","article-title":"Nanomedicine in the management of microbial infection - overview and perspectives","volume":"9","author":"Zhu X","year":"2014","unstructured":"Zhu X, Radovic-Moreno AF, Wu J, Langer R, Shi J. Nanomedicine in the management of microbial infection - overview and perspectives. Nano Today. 2014, 9:478-98. 10.1016\/j.nantod.2014.06.003","journal-title":"Nano Today"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83451-sepsis-management-controversies-and-advancement-in-nanotechnology-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:45Z","timestamp":1707507345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83451-sepsis-management-controversies-and-advancement-in-nanotechnology-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.22112","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}